Pharmaceuticals, Biotechnology and Life Sciences
Proven commercial leader with broad global experience in building and running commercial organizations and successfully launching products for people with…
Announces Results of Annual Meeting of ShareholdersTORONTO and HOUSTON, Sept. 23, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or…
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous…
MALVERN, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing…
MOUNTAIN VIEW, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on…
WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on…
Key highlights include real-world health outcomes data for pneumonia and skin infections, data on in vitro activity against B. anthracis,…
SAN JOSE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics (Nasdaq: RANI), a clinical stage biotherapeutics company focused on…
-Data from ongoing clinical trials in XLRP and ACHM shows evidence of clinical activity and tolerability; multiple data readouts expected…
NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a…